File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells

TitleFueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
Authors
KeywordsHepatocellular Carcinoma
Immune Milieu
Interactions
Liver Tumor Initiating Cells
Tumor Microenvironment
Issue Date1-Jan-2023
PublisherElsevier
Citation
Cellular and Molecular Gastroenterology and Hepatology, 2023, v. 15, n. 5, p. 1105-1116 How to Cite?
Abstract

Liver cancer (hepatocellular carcinoma) is a common cancer worldwide. It is an aggressive cancer, with high rates of tumor relapse and metastasis, high chemoresistance, and poor prognosis. Liver tumor-initiating cells (LTICs) are a distinctive subset of liver cancer cells with self-renewal and differentiation capacities that contribute to intratumoral heterogeneity, tumor recurrence, metastasis, and chemo-drug resistance. LTICs, marked by different TIC markers, have high plasticity and use diverse signaling pathways to promote tumorigenesis and tumor progression. LTICs are nurtured in the tumor microenvironment (TME), where noncellular and cellular components participate to build an immunosuppressive and tumor-promoting niche. As a result, the TME has emerged as a promising anticancer therapeutic target, as exemplified by some successful applications of tumor immunotherapy. In this review, we discuss the plasticity of LTICs in terms of cellular differentiation, epithelial–mesenchymal transition, and cellular metabolism. We also discuss the various components of the TME, including its noncellular and cellular components. Thereafter, we discuss the mutual interactions between TME and LTICs, including recently reported molecular mechanisms. Lastly, we summarize and describe new ideas concerning novel approaches and strategies for liver cancer therapy.


Persistent Identifierhttp://hdl.handle.net/10722/331715
ISSN
2023 Impact Factor: 7.1
2023 SCImago Journal Rankings: 2.702
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHuang, Hongyang-
dc.contributor.authorTsui, Yu-Man-
dc.contributor.authorNg, Irene Oi-Lin-
dc.date.accessioned2023-09-21T06:58:15Z-
dc.date.available2023-09-21T06:58:15Z-
dc.date.issued2023-01-01-
dc.identifier.citationCellular and Molecular Gastroenterology and Hepatology, 2023, v. 15, n. 5, p. 1105-1116-
dc.identifier.issn2352-345X-
dc.identifier.urihttp://hdl.handle.net/10722/331715-
dc.description.abstract<p> Liver cancer (hepatocellular carcinoma) is a common cancer worldwide. It is an aggressive cancer, with high rates of tumor relapse and metastasis, high chemoresistance, and poor prognosis. Liver tumor-initiating cells (LTICs) are a distinctive subset of liver cancer cells with self-renewal and differentiation capacities that contribute to intratumoral heterogeneity, tumor recurrence, metastasis, and chemo-drug resistance. LTICs, marked by different TIC markers, have high plasticity and use diverse signaling pathways to promote tumorigenesis and tumor progression. LTICs are nurtured in the tumor microenvironment (TME), where noncellular and cellular components participate to build an immunosuppressive and tumor-promoting niche. As a result, the TME has emerged as a promising anticancer therapeutic target, as exemplified by some successful applications of tumor immunotherapy. In this review, we discuss the plasticity of LTICs in terms of cellular differentiation, epithelial–mesenchymal transition, and cellular metabolism. We also discuss the various components of the TME, including its noncellular and cellular components. Thereafter, we discuss the mutual interactions between TME and LTICs, including recently reported molecular mechanisms. Lastly, we summarize and describe new ideas concerning novel approaches and strategies for liver cancer therapy. <br></p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofCellular and Molecular Gastroenterology and Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectHepatocellular Carcinoma-
dc.subjectImmune Milieu-
dc.subjectInteractions-
dc.subjectLiver Tumor Initiating Cells-
dc.subjectTumor Microenvironment-
dc.titleFueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells-
dc.typeArticle-
dc.identifier.doi10.1016/j.jcmgh.2023.01.007-
dc.identifier.scopuseid_2-s2.0-85150355145-
dc.identifier.volume15-
dc.identifier.issue5-
dc.identifier.spage1105-
dc.identifier.epage1116-
dc.identifier.eissn2352-345X-
dc.identifier.isiWOS:000956649800001-
dc.identifier.issnl2352-345X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats